Sphingolipid Metabolism and Obesity-Induced Inflammation
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 4, 67
- https://doi.org/10.3389/fendo.2013.00067
Abstract
Obesity is a metabolic disorder developed by overnutrition and a major cause for insulin resistance and cardiovascular events. Since adipose tissue is one of the major sites for the synthesis and secretion of cytokines, enlarged adipose tissue in obese condition alters inflammatory state leading to pathophysiological conditions such as type 2 diabetes and increased cardiovascular risk. A plausible theory for development of metabolic dysregulation is that obesity increases secretion of inflammatory cytokines from adipose tissue and causes a chronic inflammation in the whole body. Additionally accumulation of lipids in non-adipose tissues elevates the cellular levels of bioactive lipids that inhibit the signaling pathways implicated in metabolic regulation together with activated inflammatory response. Recent findings suggest that obesity-induced inflammatory response leads to modulation of sphingolipid metabolism and these bioactive lipids may function as mediators for increased risk of metabolic dysfunction. Importantly, elucidation of mechanism regarding sphingolipid metabolism and inflammatory disease will provide crucial information to development of new therapeutic strategies for the treatment of obesity-induced pathological inflammation.Keywords
This publication has 122 references indexed in Scilit:
- Endotoxin activates de novo sphingolipid biosynthesis via nuclear factor kappa B-mediated upregulation of Sptlc2Prostaglandins & Other Lipid Mediators, 2011
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectinNature Medicine, 2010
- Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanismsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategiesTrends in Pharmacological Sciences, 2009
- IRS1-Independent Defects Define Major Nodes of Insulin ResistanceCell Metabolism, 2008
- Toll‐like receptor‐4 deficiency attenuates doxorubicin‐induced cardiomyopathy in miceEuropean Journal of Heart Failure, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Cause-Specific Excess Deaths Associated With Underweight, Overweight, and ObesityJAMA, 2007
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisJournal of Hepatology, 2006
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993